Ahmed Mousa is the founder of Vicore Pharma. Vicore Pharma has raised $120M in total funding. Latest round: Series C. Backed by Nippon Shaku.
Ahmed Mousa is the CEO of Vicore Pharma, a clinical-stage biopharmaceutical company focused on treating idiopathic pulmonary fibrosis (IPF). He was appointed to this role after previously leading the company through key clinical milestones, including the completion of Phase 2A AIR trial enrollment and the initiation of the Phase 2b ASPIRE trial.
Full founder directory · Investor directory · Company funding database · Fundraising library